Stock UniverseDerived research view · source repositories remain read-only

Sangamo Therapeutics, Inc. (SGMO)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
21.47
Global Rank
3176
Market Cap
160.68M
Latest Close
0.21
RS Composite
-23.84% · G#2819

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
65.38%
3M
-43.42%
6M
-57.00%
1Y
-56.12%
3Y
-80.80%
5Y
-98.01%
10Y
-96.88%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 794.37K · 30-day average: 13.46M · Max drawdown over stored range: -99.62%

Research Snapshot

Relative Strength vs SPX

RS Composite-23.84%
20D RS114.36%
60D RS-56.53%
120D RS-60.26%
Global RS Rank2819 · 15.98% percentile
Watch+Speculative RS Rank1725 · 17.74% percentile
Group ScopeWatch+Speculative
Primary RS Rank329 · 28.17% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank409 / 701
Primary Percentile41.80
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for SGMO.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024
Revenue118.192110.701111.299176.23257.8
Revenue Growth (YoY)15.39%-6.338%0.54%58.341%-67.202%
Gross Profit-62.455-120.118-138.599-54.225-53.721
Operating Income-129.552-183.337-201.281-114.292-98.348
Free Cash Flow155.161-256.529-243.798-245.997-67.406
Free Cash Flow Per Share1.154-1.774-1.58-1.41-0.334
EPS (Diluted) GAAP-0.899939-1.233232-1.25-1.478015-0.485579
EPS Growth
EPS Non-GAAP
Gross Margin-52.842%-108.507%-124.528%-30.769%-92.943%
Operating Margin-109.611%-165.615%-180.847%-64.853%-170.152%
Profit Margin-102.372%-161.052%-172.758%-146.302%-169.448%
Free Cash Flow Margin131.279%-231.731%-219.048%-139.587%-116.619%
Shares Outstanding (Diluted)134.449144.568154.345174.444201.699
Shares Change (YoY)19.922%7.526%6.763%13.022%15.624%

SEC Quarterly Fundamentals

No processed quarterly rows for SGMO.